Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-02

Clinical Trial Update: Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating whether beta-hydroxy beta-methylbutyrate (HMB) supplementation improves post-operative muscle mass and function in female a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HMB (beta-hydroxy-beta-methylbutyrate) (beta-hydroxy-beta-methylbutyrate)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Atrophy | Phase 2 | Status: RECRUITING